David Malcom Rodman - Net Worth and Insider Trading
David Malcom Rodman Net Worth
The estimated net worth of David Malcom Rodman is at least $2 Million dollars as of 2024-11-29. David Malcom Rodman is the Chief Medical Officer of Mineralys Therapeutics Inc and owns about 140,991 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $2 Million. David Malcom Rodman is also the Exec Vice President and CMO of Alpine Immune Sciences Inc and owns about 2,842 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $184,645. Details can be seen in David Malcom Rodman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Malcom Rodman has not made any transactions after 2024-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Malcom Rodman
David Malcom Rodman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Malcom Rodman owns 2 companies in total, including Alpine Immune Sciences Inc (ALPN) , and Mineralys Therapeutics Inc (MLYS) .
Click here to see the complete history of David Malcom Rodman’s form 4 insider trades.
Insider Ownership Summary of David Malcom Rodman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | 2017-01-04 | See Remarks |
| MLYS | Mineralys Therapeutics Inc | 2024-11-11 | Chief Medical Officer |
David Malcom Rodman Latest Holdings Summary
David Malcom Rodman currently owns a total of 2 stocks. Among these stocks, David Malcom Rodman owns 140,991 shares of Mineralys Therapeutics Inc (MLYS) as of November 11, 2024, with a value of $2 Million and a weighting of 90.92%. David Malcom Rodman also owns 2,842 shares of Alpine Immune Sciences Inc (ALPN) as of January 4, 2017, with a value of $184,645 and a weighting of 9.08%.
Latest Holdings of David Malcom Rodman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics Inc | 2024-11-11 | 140,991 | 13.11 | 1,848,392 |
| ALPN | Alpine Immune Sciences Inc | 2017-01-04 | 2,842 | 64.97 | 184,645 |
Holding Weightings of David Malcom Rodman
David Malcom Rodman Form 4 Trading Tracker
According to the SEC Form 4 filings, David Malcom Rodman has made a total of 5 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Mineralys Therapeutics Inc is the sale of 5,026 shares on November 11, 2024, which brought David Malcom Rodman around $75,390.
According to the SEC Form 4 filings, David Malcom Rodman has made a total of 0 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years. The most-recent trade in Alpine Immune Sciences Inc is the sale of 1,672 shares on January 4, 2017, which brought David Malcom Rodman around $15,180.
Insider Trading History of David Malcom Rodman
- 1
David Malcom Rodman Trading Performance
David Malcom Rodman Ownership Network
David Malcom Rodman Owned Company Details
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
David Malcom Rodman is the See Remarks of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
Over the past 18 months, David Malcom Rodman made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
David Malcom Rodman Mailing Address
Above is the net worth, insider trading, and ownership report for David Malcom Rodman. You might contact David Malcom Rodman via mailing address: 3122 Sterling Circle, Suite 200, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
